OPKO Health ROA 2012-2025 | OPK
Current and historical return on assets (ROA) values for OPKO Health (OPK) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| OPKO Health ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $-0.18B | $2.00B | -8.68% |
| 2025-06-30 | $-0.18B | $1.97B | -8.27% |
| 2025-03-31 | $-0.04B | $2.13B | -1.82% |
| 2024-12-31 | $-0.05B | $2.20B | -2.52% |
| 2024-09-30 | $-0.13B | $2.26B | -6.47% |
| 2024-06-30 | $-0.24B | $1.98B | -12.07% |
| 2024-03-31 | $-0.25B | $1.97B | -12.29% |
| 2023-12-31 | $-0.19B | $2.01B | -8.95% |
| 2023-09-30 | $-0.21B | $2.06B | -9.68% |
| 2023-06-30 | $-0.21B | $2.16B | -9.59% |
| 2023-03-31 | $-0.29B | $2.17B | -13.03% |
| 2022-12-31 | $-0.33B | $2.17B | -14.47% |
| 2022-09-30 | $-0.32B | $2.23B | -13.63% |
| 2022-06-30 | $-0.20B | $2.37B | -8.51% |
| 2022-03-31 | $-0.12B | $2.31B | -4.86% |
| 2021-12-31 | $-0.03B | $2.40B | -1.23% |
| 2021-09-30 | $0.08B | $2.42B | 3.09% |
| 2021-06-30 | $0.07B | $2.42B | 2.90% |
| 2021-03-31 | $0.12B | $2.52B | 5.00% |
| 2020-12-31 | $0.03B | $2.47B | 1.32% |
| 2020-09-30 | $-0.11B | $2.37B | -4.89% |
| 2020-06-30 | $-0.20B | $2.32B | -8.62% |
| 2020-03-31 | $-0.29B | $2.23B | -12.51% |
| 2019-12-31 | $-0.32B | $2.31B | -12.98% |
| 2019-09-30 | $-0.28B | $2.37B | -11.33% |
| 2019-06-30 | $-0.25B | $2.46B | -9.84% |
| 2019-03-31 | $-0.19B | $2.58B | -7.61% |
| 2018-12-31 | $-0.15B | $2.45B | -6.09% |
| 2018-09-30 | $-0.30B | $2.48B | -11.59% |
| 2018-06-30 | $-0.30B | $2.53B | -11.63% |
| 2018-03-31 | $-0.31B | $2.58B | -11.78% |
| 2017-12-31 | $-0.31B | $2.59B | -11.29% |
| 2017-09-30 | $-0.13B | $2.72B | -4.54% |
| 2017-06-30 | $-0.10B | $2.77B | -3.75% |
| 2017-03-31 | $-0.07B | $2.76B | -2.56% |
| 2016-12-31 | $-0.05B | $2.77B | -1.72% |
| 2016-09-30 | $-0.01B | $2.80B | -0.32% |
| 2016-06-30 | $0.13B | $2.77B | 4.71% |
| 2016-03-31 | $0.08B | $2.79B | 2.96% |
| 2015-12-31 | $-0.03B | $2.80B | -1.36% |
| 2015-09-30 | $-0.09B | $3.02B | -4.64% |
| 2015-06-30 | $-0.26B | $1.53B | -18.71% |
| 2015-03-31 | $-0.24B | $1.51B | -18.07% |
| 2014-12-31 | $-0.17B | $1.27B | -13.11% |
| 2014-09-30 | $-0.14B | $1.30B | -10.13% |
| 2014-06-30 | $-0.15B | $1.33B | -10.77% |
| 2014-03-31 | $-0.13B | $1.36B | -10.48% |
| 2013-12-31 | $-0.12B | $1.39B | -11.30% |
| 2013-09-30 | $-0.10B | $1.38B | -13.34% |
| 2013-06-30 | $-0.05B | $0.64B | -10.68% |
| 2013-03-31 | $-0.06B | $0.65B | -16.01% |
| 2012-12-31 | $-0.03B | $0.29B | -12.38% |
| 2012-09-30 | $-0.01B | $0.25B | -5.10% |
| 2012-06-30 | $-0.01B | $0.23B | -5.23% |
| 2012-03-31 | $-0.01B | $0.23B | -3.11% |
| 2011-12-31 | $0.00B | $0.23B | -1.68% |
| 2011-09-30 | $-0.02B | $0.15B | -15.58% |
| 2011-06-30 | $-0.02B | $0.16B | -17.43% |
| 2011-03-31 | $-0.02B | $0.18B | -22.56% |
| 2010-12-31 | $-0.02B | $0.08B | -27.91% |
| 2010-09-30 | $-0.03B | $0.07B | -38.71% |
| 2010-06-30 | $-0.03B | $0.07B | -39.26% |
| 2010-03-31 | $-0.03B | $0.09B | -38.99% |
| 2009-12-31 | $-0.04B | $0.09B | -56.00% |
| 2009-09-30 | $-0.04B | $0.08B | -75.68% |
| 2009-06-30 | $-0.03B | $0.06B | -100.76% |
| 2009-03-31 | $-0.04B | $0.02B | -165.22% |
| 2008-12-31 | $-0.04B | $0.02B | -153.85% |
| 2008-09-30 | $-0.04B | $0.03B | -127.87% |
| 2008-06-30 | $-0.03B | $0.02B | -116.50% |
| 2008-03-31 | $-0.03B | $0.03B | -127.66% |
| 2007-12-31 | $-0.27B | $0.04B | -1345.00% |
| 2007-09-30 | $-0.01B | $0.01B | -100.00% |
| 2007-06-30 | $-0.01B | $0.01B | -115.79% |
| 2007-03-31 | $0.00B | $0.02B | 0.00% |
| 2006-12-31 | $0.00B | $0.00B | -14.81% |
| 2006-09-30 | $-0.25B | $0.01B | -2788.89% |
| 2006-06-30 | $-0.25B | $0.01B | -2777.78% |
| 2006-03-31 | $-0.25B | $0.01B | -2777.78% |
| 2005-12-31 | $0.00B | $0.01B | 0.00% |
| 2005-09-30 | $0.00B | $0.01B | 0.00% |
| 2005-06-30 | $0.00B | $0.01B | -10.53% |
| 2005-03-31 | $0.00B | $0.01B | -20.51% |
| 2004-12-31 | $0.00B | $0.01B | -20.51% |
| 2004-09-30 | $0.00B | $0.01B | -40.00% |
| 2004-06-30 | $-0.01B | $0.01B | -55.81% |
| 2004-03-31 | $-0.01B | $0.01B | -59.57% |
| 2003-12-31 | $-0.01B | $0.01B | -52.83% |
| 2003-09-30 | $-0.01B | $0.01B | -60.00% |
| 2003-06-30 | $-0.01B | $0.01B | -57.97% |
| 2003-03-31 | $-0.01B | $0.02B | -50.63% |
| 2002-12-31 | $-0.01B | $0.02B | -49.44% |
| 2002-09-30 | $-0.01B | $0.02B | -36.36% |
| 2002-06-30 | $-0.01B | $0.02B | -32.73% |
| 2002-03-31 | $-0.01B | $0.03B | -33.61% |
| 2001-12-31 | $-0.01B | $0.03B | -31.01% |
| 2001-09-30 | $-0.01B | $0.03B | -26.09% |
| 2001-06-30 | $-0.01B | $0.03B | -22.22% |
| 2001-03-31 | $-0.01B | $0.04B | -15.89% |
| 2000-12-31 | $-0.01B | $0.04B | -18.05% |
| 2000-09-30 | $-0.01B | $0.04B | -24.00% |
| 2000-06-30 | $-0.01B | $0.04B | -29.41% |
| 2000-03-31 | $-0.01B | $0.02B | -58.82% |
| 1999-12-31 | $0.00B | $0.00B | -69.57% |
| 1999-09-30 | $0.00B | $0.01B | -59.26% |
| 1999-06-30 | $0.00B | $0.01B | -53.33% |
| 1999-03-31 | $0.00B | $0.01B | -35.29% |
| 1998-12-31 | $0.00B | $0.01B | -41.38% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.952B | $0.713B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $203.946B | 23.74 |
| Intuitive Surgical (ISRG) | United States | $173.357B | 66.87 |
| IDEXX Laboratories (IDXX) | United States | $51.473B | 49.32 |
| Edwards Lifesciences (EW) | United States | $45.675B | 30.63 |
| Alcon (ALC) | Switzerland | $38.991B | 26.28 |
| IQVIA Holdings (IQV) | United States | $31.930B | 17.25 |
| Mettler-Toledo (MTD) | United States | $28.059B | 32.10 |
| DexCom (DXCM) | United States | $27.289B | 37.62 |
| STERIS (STE) | Ireland | $24.749B | 25.02 |
| Waters (WAT) | United States | $22.705B | 30.02 |
| Coloplast (CLPBY) | Denmark | $17.601B | 26.93 |
| Hologic (HOLX) | United States | $16.701B | 17.48 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.912B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.959B | 11.58 |
| Penumbra (PEN) | United States | $13.355B | 93.94 |
| Globus Medical (GMED) | United States | $11.752B | 24.67 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $7.474B | 23.95 |
| Glaukos (GKOS) | United States | $6.463B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.024B | 19.14 |
| Teleflex (TFX) | United States | $4.792B | 7.64 |
| TransMedics (TMDX) | United States | $4.616B | 54.68 |
| LivaNova (LIVN) | United Kingdom | $3.635B | 19.63 |
| Integer Holdings (ITGR) | United States | $3.029B | 14.22 |
| Veracyte (VCYT) | United States | $2.861B | 32.60 |
| Elekta AB (EKTAY) | Sweden | $2.241B | 20.97 |
| UFP Technologies (UFPT) | United States | $2.062B | 27.22 |
| Alphatec Holdings (ATEC) | United States | $2.053B | 0.00 |
| Artivion (AORT) | United States | $1.876B | 86.07 |
| Nihon Kohden (NHNKY) | Japan | $1.855B | 20.47 |
| AxoGen (AXGN) | United States | $1.611B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.606B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.406B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.300B | 0.00 |
| IRadimed (IRMD) | United States | $1.221B | 58.16 |
| Integra LifeSciences Holdings (IART) | United States | $0.877B | 4.75 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.677B | 13.51 |
| SiBone (SIBN) | United States | $0.676B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.623B | 36.25 |
| Alpha Tau Medical (DRTS) | Israel | $0.603B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.576B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.549B | 0.00 |
| NeuroPace (NPCE) | United States | $0.522B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.515B | 13.42 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.507B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.435B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.418B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.383B | 0.00 |
| RxSight (RXST) | United States | $0.345B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.331B | 55.12 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.310B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.283B | 0.00 |
| 908 Devices (MASS) | United States | $0.237B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.226B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.177B | 0.00 |
| CVRx (CVRX) | United States | $0.172B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.172B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.168B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.160B | 0.00 |
| Inogen (INGN) | United States | $0.154B | 0.00 |
| LENSAR (LNSR) | United States | $0.144B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.144B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.118B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.118B | 0.00 |
| Hyperfine (HYPR) | United States | $0.107B | 0.00 |
| Neuronetics (STIM) | United States | $0.107B | 0.00 |
| Solana (HSDT) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.083B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| Accuray (ARAY) | United States | $0.070B | 0.00 |
| DarioHealth (DRIO) | United States | $0.067B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.060B | 0.00 |
| Positron (POSC) | United States | $0.058B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.046B | 0.00 |
| Precision Optics (POCI) | United States | $0.044B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.027B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.024B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Envoy Medical (COCH) | United States | $0.014B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| NexGel (NXGL) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |